The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Tumor burden kinetics and estimation of TTP for the evaluation of response and resistance to therapy in phase II clinical trials.
Nadine Houede
No relevant relationships to disclose
Nicolas Penel
No relevant relationships to disclose
Thomas Filleron
No relevant relationships to disclose
Andrew Kramar
No relevant relationships to disclose